Tocilizumab in Cardiac Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Status
- RECRUITING
- Phase
- N/A
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
- Status
- COMPLETED
- Phase
- PHASE1
CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
- Status
- UNKNOWN
- Phase
- N/A
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Status
- COMPLETED
- Phase
- PHASE1
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
- Status
- UNKNOWN
- Phase
- PHASE4
An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
- Status
- COMPLETED
- Phase
- PHASE3